Table 7
Baseline and on-study grade 3-4 cytopenias associated with dasatinib
.
No. (%) of patients
.
Baseline
.
8 months' follow-up
.
Leukocytopenia
5 (14)
23 (64)
Neutropenia
7 (19)
26 (72)
Thrombocytopenia
18 (50)
28 (78)
Anemia
0
17 (47)
.
No. (%) of patients
.
Baseline
.
8 months' follow-up
.
Leukocytopenia
5 (14)
23 (64)
Neutropenia
7 (19)
26 (72)
Thrombocytopenia
18 (50)
28 (78)
Anemia
0
17 (47)
View Large
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal